0001127602-21-029702.txt : 20211119 0001127602-21-029702.hdr.sgml : 20211119 20211119162804 ACCESSION NUMBER: 0001127602-21-029702 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211117 FILED AS OF DATE: 20211119 DATE AS OF CHANGE: 20211119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Petersohn Walter CENTRAL INDEX KEY: 0001501954 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16211 FILM NUMBER: 211428694 MAIL ADDRESS: STREET 1: C/O DENTSPLY SIRONA INC STREET 2: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DENTSPLY SIRONA Inc. CENTRAL INDEX KEY: 0000818479 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 391434669 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 BUSINESS PHONE: 844-546-3722 MAIL ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 FORMER COMPANY: FORMER CONFORMED NAME: DENTSPLY INTERNATIONAL INC /DE/ DATE OF NAME CHANGE: 19930630 FORMER COMPANY: FORMER CONFORMED NAME: GENDEX CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-11-17 0000818479 DENTSPLY SIRONA Inc. XRAY 0001501954 Petersohn Walter 13320 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277 1 Chief Commercial Officer Common Stock 2021-11-17 4 S 0 34068 54.297 D 36487.1034 D Common Stock 2021-11-17 4 S 0 10747 54.0832 D 25740.1034 D Common Stock 2021-11-17 4 M 0 17748 47.41 A 43488.1034 D Common Stock 2021-11-17 4 S 0 17748 54.107 D 25740.1034 D Common Stock 2021-11-17 4 M 0 9300 40.12 A 35040.1034 D Common Stock 2021-11-17 4 S 0 9300 54.085 D 25740.1034 D Common Stock 2021-11-17 4 M 0 9134 49.29 A 34874.1034 D Common Stock 2021-11-17 4 S 0 9134 54.123 D 25740.1034 D Common Stock 2021-11-17 4 M 0 5434 47.84 A 31174.1034 D Common Stock 2021-11-17 4 S 0 5434 54.094 D 25740.1034 D Stock Option (Right to Buy) 47.41 2021-11-17 4 M 0 17748 0 D 2024-11-25 Common Stock 17748 0 D Stock Option (Right to Buy) 40.12 2021-11-17 4 M 0 9300 0 D 2028-08-09 Common Stock 9300 0 D Stock Option (Right to Buy) 49.29 2021-11-17 4 M 0 9134 0 D 2029-03-12 Common Stock 9134 4566 D Stock Option (Right to Buy) 47.84 2021-11-17 4 M 0 5434 0 D 2030-03-04 Common Stock 5434 10866 D The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.19 to $54.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.05 to $54.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.06 to $54.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.00 to $54.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. This option is fully vested and exercisable. This option is fully vested and exercisable. Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 12, 2022. Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 4, 2023. /s/ Dane Baumgardner, Attorney-In-Fact for Walter Petersohn 2021-11-19